Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

KalVista Pharmaceuticals, Inc. (KALV)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsApr-30-23Apr-05-23Apr-30-22Apr-05-22Apr-30-21Apr-30-20Apr-30-19Apr-30-18
   10-K8-K10-K8-K10-K10-K10-K10-K
Revenues   [+]0.080.30.070.20.012.716.18.4
            Revenue growth   14.4%  -100.0%-21.3%92.1%458.1%
Cost of goods sold  0.0160.60.0140.30.00.00.00.0
Gross profit  0.0-80.30.0-70.20.012.716.18.4
            Gross margin   -100.0% -100.0% 100.0%100.0%100.0%
Selling, general and administrative   [+]30.630.626.426.416.613.010.98.9
Research and development  80.3 70.2 41.340.235.018.2
EBITDA   [+]-110.2-110.2-96.0-96.0-57.4-40.0-29.4-18.5
            EBITDA margin   -137.2% -136.9% -315.4%-182.6%-220.7%
Depreciation and amortization  0.70.70.60.60.50.50.40.2
EBIT   [+]-110.9-110.9-96.6-96.6-57.9-40.5-29.8-18.7
            EBIT margin   -138.1% -137.7% -319.4%-184.9%-222.8%
Interest income  2.2 1.1 0.91.81.40.1
Other income (expense), net   [+]15.718.013.214.310.89.57.72.8
Pre-tax income  -92.9-92.9-82.3-82.3-46.2-29.2-20.7-15.8
Income taxes  0.00.00.00.00.0-0.10.10.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.4% 0.0%
Net income  -92.9-92.9-82.3-82.3-46.2-29.1-20.8-15.8
            Net margin   -115.7% -117.3% -229.4%-129.1%-188.3%
   
Basic EPS   [+]($3.33)($3.33)($3.36)($3.36)($2.42)($1.64)($1.38)($1.53)
Diluted EPS   [+]($3.33)($3.33)($3.36)($3.36)($2.42)($1.64)($1.38)($1.53)
   
Shares outstanding (basic)   [+]27.927.924.524.519.117.715.110.3
Shares outstanding (diluted)   [+]27.927.924.524.519.117.715.110.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy